Dr. Vagelos served as the chair and CEO of Merck from 1984 to 1994. In 1995, he joined Regeneron Pharmaceuticals as chairman and led the company for nearly 29 years. He also served as chairman and co-founder of pharmaceutical company Theravance.
According to a 2015 article from Bloomberg, Dr. Vagelos accumulated his wealth after he joined Regeneron Pharmaceuticals board following his retirement from Merck. There, he earned $1.3 billion from his director compensation.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.